Table 3.
Plasmid virus | Intercept parameters with: |
Slope parameters with: |
Efficiency parameters with: |
||||||
---|---|---|---|---|---|---|---|---|---|
FAM-RIp | Cy5-ENp | BOXTO | FAM-RIp | Cy5-ENp | BOXTO | FAM-RIp | Cy5-ENp | BOXTO | |
HRV-A1b | 40.17 | 39.15 | −3.43 | −3.31 | 0.96 | 1.00 | |||
HRV-B14 | 38.92 | 41.25 | −3.48 | −3.35 | 0.94 | 0.99 | |||
HRV-A85 | 40.04 | 41.93 | −3.37 | −3.30 | 0.98 | 1.01 | |||
CVA16 | 39.97 | 39.82 | −3.36 | −3.32 | 0.98 | 1.00 | |||
CVB4 | 40.71 | 39.20 | −3.33 | −3.24 | 1.00 | 1.03 | |||
EV11 | 39.46 | 42.60 | −3.33 | −3.24 | 1.00 | 1.04 |
Linear regression curves (y = mx + b, where y = CT, m = slope, x = log10[copies/PCR], and b = intercept when x = 0) and efficiencies (E = 10−1/m − 1) were determined with 10-fold dilutions containing 5 × 107 to 5 plasmid copies/reaction.